Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar;18(1):19-26.
doi: 10.26574/maedica.2023.18.1.19.

Foot Osteomyelitis Caused by Multidrug- and Extensively Drug-Resistant Gram-Negative Bacteria

Affiliations
Editorial

Foot Osteomyelitis Caused by Multidrug- and Extensively Drug-Resistant Gram-Negative Bacteria

Efthymia Giannitsioti et al. Maedica (Bucur). 2023 Mar.

Abstract

There are scarce data regarding foot osteomyelitis (FO) caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB). This study investigates the causative organisms, the diagnostic and therapeutic approach and the outcome of these infections. All patients with FO caused by MDR and/or XDR GNB who received treatment in the Department of osseous infectious diseases of the "Attikon" University Hospital of Athens, Greece, were recorded and evaluated during a six-year-period. Seventeen patients, of which 64.7% females, with a mean age of 54.06 years were studied. There were nine cases with diabetic (DFO), and 76.5% of patients reported previous use of antimicrobials. Pathogens were isolated from soft-tissue biopsies or intra-operative tissue samples (n=12) and/or affected bone samples (n=5). In most cases, E. coli and P. aeruginosa were isolated (each 29.4%), followed by P. mirabilis (11.7%), while polymicrobial infection was detected in nine patients (53%). Most cases were given antimicrobial monotherapy (88.2%) with a mean duration of 90.05 days, while surgery significantly promoted cure of the infection. Foot and DFO cases represent a challenging to treat disease, requiring a multidisciplinary approach. Surgical treatment remains the cornerstone of treatment, while it is of utmost importance to isolate the causative organisms. MDR and XDR GNB represent an emerging threat and more data are needed to better understand these infections.

PubMed Disclaimer

Figures

TABLE 1.
TABLE 1.
Clinical characteristics, treatment and outcome in MDR vs XDR FO cases. MDR=multidrug-resistant; XDR=extensively drug-resistant; FO=foot osteomyelitis
TABLE 2.
TABLE 2.
Antimicrobial resistance profile of Gram-negative causative pathogens. MDR=multidrug-resistant; XDR=extensively drug-resistant
TABLE 3.
TABLE 3.
Medical and surgical treatment of 17 patients with MDR/XDR GNB foot osteomyelitis. GNB=Gram-negative bacteria; MDR=multidrug-resistant; XDR=extensively drug-resistant; MER=meropenem; ERT=ertapenem; IMI/CL=imipenem/cilastatin; CIPR=ciprofloxacin; AMOX/CLAV=amoxicillin/clavulanate; CEFT=ceftazidime; PIP/TAZ=piperacillin/tazobactam; TYG=tigecycline; AZT=aztreonam; MIN=minocycline; COTR=cotrimoxazole; COL=colistin; antimicrobials linked by “+” correspond to combination treatment; if separated by “,” consecutive administration is indicated
TABLE 4.
TABLE 4.
Univariate analysis for factors associated with lack of cure in patients with FO by MDR/XDR GNB. MDR GNB=multidrug-resistant Gram-negative bacteria; XDR GNB=extensively drug-resistant Gram-negative bacteria; FO=foot osteomyelitis
FIGURE 1.
FIGURE 1.
Kaplan-Meier survival analysis presenting the impact of surgery on foot osteomyelitis outcome

Similar articles

References

    1. King CM, Castellucci-Garza FM, Lyon L, et al. Microorganisms Associated With Osteomyelitis of the Foot and Ankle. J Foot Ankle Surg. 2020;59:491–494. - PubMed
    1. Lindbloom BJ, James ER, McGarvey WC. Osteomyelitis of the foot and ankle: diagnosis, epidemi-ology, and treatment. Foot Ankle Clin. 2014;19:569–88. - PubMed
    1. Andrianaki AM, Koutserimpas C, Kafetzakis A, et al. Diabetic foot infection and osteomyelitis. Are deep-tissue cultures neces-sary? Germs. 2020;10:346–355. - PMC - PubMed
    1. Lipsky BA, Uçkay İ. Treating Diabetic Foot Osteomyelitis: A Practical State-of-the-Art Update. Medicina (Kaunas) 2021. - PMC - PubMed
    1. Pitocco D, Spanu T, Di Leo M, et al. Diabetic foot infections: a comprehen-sive overview. Eur Rev Med Pharmacol Sci. 2019;23(2 Suppl):26–37. - PubMed

Publication types

LinkOut - more resources